Key statistics
On Wednesday, Calidi Biotherapeutics Inc (CLDI:ASQ) closed at 1.01, 0.00% above its 52-week low of 1.01, set on Aug 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.02 |
---|---|
High | 1.08 |
Low | 1.01 |
Bid | 1.01 |
Offer | 1.03 |
Previous close | 1.08 |
Average volume | 72.58k |
---|---|
Shares outstanding | 8.08m |
Free float | 5.96m |
P/E (TTM) | -- |
Market cap | 8.73m USD |
EPS (TTM) | -5.41 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 20:59 BST.
More ▼
Announcements
- Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
- Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
- Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor
- Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
- Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
More ▼